Ambit, Daiichi Sankyo deal

Daiichi Sankyo began its tender offer to acquire Ambit Biosciences for up to $19.50 per share, or about $415 million on a fully diluted basis. The tender expires at 5 p.m. EST on Nov. 10 (see BioCentury, Oct. 6). ...